Rapid Pathogen Detection PathogenDx's innovative D3 Array technology enables rapid, multiplexed detection of up to 50 pathogens simultaneously, making it a valuable asset for food safety, agricultural health, and clinical diagnostics markets seeking quick and reliable testing solutions.

Market Expansion Opportunities Recent product launches, including the unified Salmonella testing system and a comprehensive suite of Salmonella detection tools, position PathogenDx to capitalize on growing demand from poultry processing and food safety sectors focused on reducing contamination and meeting regulatory standards.

Technology Integration The company's equipment-agnostic, automated cloud-based software enhances ease of use and scalability, offering sales opportunities to laboratories and testing facilities looking for flexible, tech-forward pathogen detection solutions.

Strategic Collaborations With recent board advisory hires like Dr. Carl Wittwer and ongoing research partnerships, PathogenDx is strengthening its technical expertise and industry presence, opening doors for collaborations with bio labs, research institutions, and government agencies.

Funding and Growth With over 11 million dollars in funding and revenue between 1 and 10 million dollars, PathogenDx is positioned for growth, making it a promising partner for investors and organizations interested in innovative biotech testing technologies within the food, clinical, and agricultural markets.